£215 million additional investment for UK innovation centres

The £215 million investment is in the Digital, Medicines Discovery, Future Cities and Transport Systems Catapult centres.

It builds on the announcement made in August by the Chancellor of the Exchequer, Phillip Hammond, of nearly £1 billion for the Catapult network and fully funds all centres for the next 5 years. The Catapult network is managed by Innovate UK, part of UK Research and Innovation.

Combining knowledge

The Future Cities and Transport Systems Catapult centres will be combining to bring together their skills and expertise in tackling the problems of modern city living and shaping the future of mobility.

The UK’s urban areas are home to 83% of the population and by 2050 more than two-thirds of people worldwide will live in urban areas. The world of transport will transform dramatically over the coming decade as new technology – such as decarbonised power sources, AI and big data – radically transforms the way that people, goods and services move around our towns and countryside.

The new Catapult will help businesses to access the UK’s world-leading research expertise more easily, enabling them to grow faster, create more jobs and keep the UK at the forefront of urban and transport innovation. The centre will operate from sites in London and Milton Keynes.

Network of world-leading centres

The Catapults are a network of world-leading centres that are designed to transform the UK’s capability for innovation in specific areas. They are helping to drive future prosperity by transforming high-potential ideas into new products and services that generate economic growth for the UK.

The Digital Catapult is making UK industries more productive and competitive by supporting them to take up advanced digital technologies, such as AI, 5G and augmented and virtual reality. Businesses working with the Digital Catapult grow their employment numbers by over 15%, which is 3 times higher than seen in the wider economy.

The Medicines Discovery Catapult is focused on using newly industrialised technologies to deliver new medicines to patients, faster. For example, they have recently announced a collaboration with AstraZeneca to use the power of sound to speed up the process of early drug discovery.

The Catapult is helping to grow the UK’s bio-economy, creating jobs and attracting investment into the country, so that we are able to maintain our position as a global leader in medicinal research and development.